Royal Bank Of Canada Bristol Myers Squibb CO Transaction History

Royal Bank Of Canada

$458 Billion
Q1 2025

A detailed history of Royal Bank Of Canada transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Royal Bank Of Canada holds 13,378,395 shares of BMY stock, worth $625 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

13,378,395

Previous 14,375,911 6.94%

Holding current value

$625 Million

Previous $813 Million 0.35%

% of portfolio

0.18%

Previous 0.17%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$53.9 - $63.11 $53.8 Million - $63 Million	-997,516 Reduced 6.94%	13,378,395 $816 Million
Q4 2024 Feb 14, 2025	BUY	$51.92 - $59.94 $185 Million - $214 Million	3,564,580 Added 32.97%	14,375,911 $813 Million
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $158 Million - $206 Million	3,974,196 Added 58.13%	10,811,331 $559 Million
Q2 2024 Nov 06, 2024	SELL	$40.25 - $52.99 $4.96 Million - $6.53 Million	-123,168 Reduced 1.77%	6,837,135 $284 Million
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $40.7 Million - $53.6 Million	-1,011,443 Reduced 12.69%	6,960,303 $289 Million
Q1 2024 Nov 05, 2024	BUY	$47.98 - $54.4 $45.4 Million - $51.5 Million	946,429 Added 13.6%	7,906,732 $429 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $54.9 Million - $62.2 Million	1,143,273 Added 16.74%	7,971,746 $432 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $24.7 Million - $29.5 Million	510,017 Added 8.07%	6,828,473 $350 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $10.3 Million - $11.5 Million	-177,653 Reduced 2.73%	6,318,456 $367 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $39 Million - $43.3 Million	612,349 Added 10.41%	6,496,109 $415 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $76.6 Million - $86.9 Million	-1,165,523 Reduced 16.53%	5,883,760 $408 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $75.3 Million - $89.2 Million	1,100,213 Added 18.49%	7,049,283 $507 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $2,783 - $1.65 Million	-21,409 Reduced 0.36%	5,949,070 $423 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $1.54 Million - $1.7 Million	21,248 Added 0.36%	5,970,479 $460 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $98 Million - $118 Million	-1,594,504 Reduced 21.14%	5,949,231 $434 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $80.1 Million - $93.4 Million	1,494,326 Added 24.7%	7,543,735 $470 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $69.1 Million - $80.9 Million	-1,167,278 Reduced 16.17%	6,049,409 $358 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $447 Million - $487 Million	7,216,687 New	7,216,687 $482 Million

Others Institutions Holding BMY

# of Institutions

2,801

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.4B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Bristol Myers Squibb CO Transaction History